Gastrointestinal and Hepatic Manifestations of COVID-19 in Children: A Systematic Review and Meta-analysis
Gastrointestinale und hepatische Manifestationen von COVID-19 bei Kindern: systematische Übersichtsarbeit und Metaanalyse
Acta Medica Philippina · 30.04.2024 · 58 (7)
DOI: 10.47895/amp.v58i7.7054 ↗Auf einen Blick
Bei Kindern mit COVID-19 trat bei etwa einem Drittel mindestens ein GI-Symptom auf. Schwere COVID-19 und MIS-C waren mit häufigeren GI- bzw. hepatischen Befunden verbunden.
Fragestellung
Welche gastrointestinalen und hepatischen Manifestationen treten bei Kindern mit COVID-19 auf, und wie sind sie mit der Schwere der Erkrankung assoziiert?
Methode
Systematische Literaturrecherche bis 4. Januar 2021 in PubMed, Cochrane Library, Google Scholar und Prepublication-Repositorien; Metaanalyse gepoolter Prävalenzen.
Ergebnisse
58 Studien mit 4497 Teilnehmenden. Mindestens ein GI-Symptom: 33,8 % (95 %-KI 23,0–45,4; 42 Studien, 3327 Teilnehmende). Schwere COVID-19: OR 2,59 (95 %-KI 1,35–4,99) für GI-Symptome. AST 11,3 % und ALT 11,2 %.
Einschränkungen
Hohe Heterogenität; bei Ausschluss von Studien schlechter Qualität nicht verbessert.
Schlussfolgerung der Autor:innen
Etwa ein Drittel der Kinder mit COVID-19 zeigte mindestens ein GI-Symptom, häufiger bei schwerer Erkrankung. Erhöhte Transaminasen traten bei 10 % auf; bei MIS-C waren GI- und hepatische Manifestationen häufiger.
Kernaussagen
- Mindestens ein GI-Symptom bei 33,8 % der Kinder
- Schwere COVID-19: OR 2,59 für GI-Symptome
- Erhöhte Transaminasen bei etwa 10 %; häufiger bei MIS-C
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Acta Medica Philippina, online erschienen am 30.04.2024. Verfasst von April P Padua-Zamora und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Philippine General Hospital, University of the Philippine…. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Children with COVID-19 may present with gastrointestinal (GI) symptoms and liver dysfunction.
Objective
To determine the type and prevalence of gastrointestinal (GI) and hepatic manifestations of COVID-19 in children and its association with severity of illness.
Methods
A systematic literature search was done from inception until January 4, 2021 using PubMed, CochraneLibrary, Google Scholar and prepublication repositories with no language restrictions. Studies that reported thedemographic and clinical features of children with COVID-19 and provided data on their GI and hepatic signs and symptoms were included. Prevalence of GI and hepatic manifestations were pooled using Stata14.
Results
We included 58 studies with total of 4497 participants. Overall, one-third of children with COVID-19presented with at least one GI symptom (33.8%; 95% confidence interval (CI) 23.0, 45.4; I2 97.5%; 42 studies, 3327 participants) with abdominal pain, nausea or vomiting, and diarrhea each occurring in approximately 20%. Children with severe COVID-19 were more likely to present with GI symptoms (odds ratio 2.59; 95% CI 1.35, 4.99; I2 24%; 4 studies, 773 participants). The pooled prevalence of elevated transaminases was 11% for both AST (11.3%, 95% CI 4.9, 19.3; I2 74.7%; 11 studies, 447 participants) and ALT (11.2%, 95% CI 7.1, 16.0; I2 40.8%; 15 studies, 513 participants). Hepatic findings such as jaundice (2-17%), hepatomegaly (2%) or behavioral changes (2%) from hepatic encephalopathy were variably reported by a few studies. The degree of heterogeneity was not improved on exclusion of studies with poor quality, but markedly improved on subgroup analysis according to geographical region and presence of MIS-C. Studies from China showed that children with COVID-19 had significantly lower pooled prevalence for any of the GI symptoms with low degree of heterogeneity, particularly for diarrhea, nausea/vomiting, and abdominal pain, all of which had I2 of 0%. Those with multisystem inflammatory syndrome in children (MIS-C) had significantly more common GI symptoms and increased transaminases than those without.
Conclusion
One-third of children with COVID-19 exhibit at least one GI symptom and more likely presentin those with severe disease. Elevated transaminases were present in 10%. Prevalence of GI and hepaticmanifestations were higher among children with MIS-C.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila.
- Division of Allergy and Immunology, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila.
Zitieren
APA
Padua-Zamora, A. P., Rey, K. L. R., Tan-Lim, C. S. C., & Gregorio, G. E. V. (2024). Gastrointestinal and Hepatic Manifestations of COVID-19 in Children: A Systematic Review and Meta-analysis. Acta Medica Philippina, 58(7). https://doi.org/10.47895/amp.v58i7.7054
Vancouver
Padua-Zamora AP, Rey KLR, Tan-Lim CSC, Gregorio GEV. Gastrointestinal and Hepatic Manifestations of COVID-19 in Children: A Systematic Review and Meta-analysis. Acta Medica Philippina. 2024;58(7). doi:10.47895/amp.v58i7.7054
BibTeX
@article{PaduaZamora2024,
author = {Padua-Zamora, April P and Rey, Katrina Loren R and Tan-Lim, Carol Stephanie C and Gregorio, Germana Emerita V},
title = {Gastrointestinal and Hepatic Manifestations of COVID-19 in Children: A Systematic Review and Meta-analysis},
journal = {Acta Medica Philippina},
year = {2024},
volume = {58},
number = {7},
doi = {10.47895/amp.v58i7.7054}
}
EUVIMED